The device manufacturing lifecycle links intended purpose and design evidence to controlled production, release and post-market feedback. Each handover should identify the evidence required by the receiving team.
Define intended purpose and risk
Document the device, users, use environment and applicable markets. Translate hazards, foreseeable misuse and user needs into verifiable design inputs and risk controls.
- Gate: Approved design inputs and risk management plan.
Verify, validate and transfer
Verification checks design outputs against inputs. Validation examines whether the device meets user needs and intended use under representative conditions. Transfer approved drawings, specifications, methods and acceptance criteria into controlled manufacturing documents.
- Gate: Traceability from risk control to verified design and production instructions.
Qualify suppliers and production
Review critical components, outsourced services and sub-tier dependencies. Qualify equipment and validate processes where subsequent monitoring or measurement cannot adequately verify output. Check packaging and sterilization evidence where applicable.
- Gate: Supplier approval, process readiness and operator training.
Manufacture and release
Use controlled instructions, traceable lot or serial information where applicable, and documented acceptance activities. Review nonconformities and applicable labeling and packaging controls before release by the authorized function.
- Gate: Production history and documented release authorization.
Monitor the field
Assess complaints, service records, returns and adverse events against applicable reporting requirements. Feed relevant signals into risk review, CAPA, design changes and field actions.
- Gate: Documented triage, reporting decision and feedback to the risk file.
Authoritative references
- ISO 13485:2016 — Medical device quality management systems
- ISO 14971:2019 — Medical device risk management
- DRAP — Medical Devices Rules, 2017, consolidated through April 2022
- DRAP — Medical Devices Rules amendment, S.R.O. 1049(I)/2025
- FDA — Quality Management System Regulation
Related MHPL solution Medical Devices

Quality nucleus